IL6 and inflammatory bowel disease: Likewise, the pre-treatment of NaB obviously represses the expression levels of IL-6 and TNF-α in RAW246.7 macrophages induced by lipopolysaccharide in vitro, suggesting its anti-inflammatory property in inflammatory bowel disease [39].